speb/financial-data huggingface dataset:
Financial ratios for AIL.DE — annual report dated 2022-12-31
Total revenue: 31844680851.06383
Gross profit: 17150000000.000002
Operating income: 5172127659.574469
Net income: 3089255319.1489363
Capital expenditures: 3384042553.1914897
Operating cash flow: 6180957446.808511
Depreciation & amortization: 2623297872.3404255
Net tangible assets: 7806170212.765958
Owner earnings: 2328510638.297872
Return on net tangible assets (%): 29.829104091144483
Capex to operating income (%): 65.4284421407709
Buffett classification: The Good
Stock price: 120.90425531914894
P/E ratio: 24.886015369124284
Shares outstanding: 635868896
Book value: 26140425531.914898
P/B ratio: 2.94101009402572
Market cap (USD): 76879255351.48936
Debt to equity: 0.5443472244831515
Current ratio: 0.9260358355252805
Quick ratio: 0.7056046401834491
Effective tax rate (%): 25.666436198816932
Interest coverage ratio: 108.52232142857143
COGS to revenue (%): 46.14485200775039
Free cash flow (dilution-adjusted): 2699042553.1914897
Buyback yield (%): 0.2649913859387719
Retained earnings: 19815744680.851067
Inventory turnover: 7.043855175930648
Receivables turnover: 9.863582443653618
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.968450437942188
FCF margin (%): 8.475646422128683
Rule of 40 score: 8.475646422128683
Financial ratios for AIL.DE — annual report dated 2023-12-31
Total revenue: 30675111111.11111
Gross profit: 18289777777.77778
Operating income: 5631111111.111111
Net income: 3542666666.6666665
Capital expenditures: 3700222222.2222223
Operating cash flow: 6958888888.888888
Depreciation & amortization: 2757777777.7777777
Net tangible assets: 9440000000
Owner earnings: 2600222222.2222223
Return on net tangible assets (%): 27.544726930320152
Capex to operating income (%): 65.71033938437255
Buffett classification: The Good
Stock price: 169.5
P/E ratio: 30.423347159954837
Shares outstanding: 635868896
Book value: 27825666666.666664
P/B ratio: 3.8733942716676455
Market cap (USD): 107779777872
Debt to equity: 0.4806753157556373
Current ratio: 0.8724395206873162
Quick ratio: 0.643228577888311
Effective tax rate (%): 23.386999735277836
Interest coverage ratio: 69.3296853625171
COGS to revenue (%): 40.37583853721439
Free cash flow (dilution-adjusted): 3188444444.444444
Buyback yield (%): 0.08443142284823803
Retained earnings: 21268555555.555553
Inventory turnover: 5.497534030380746
Receivables turnover: 9.221899321909344
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.834798816807814
FCF margin (%): 10.394239267448095
Revenue growth (%): -3.672731861948144
Rule of 40 score: 6.721507405499951
Financial ratios for AIL.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 10615729166.666668
Buffett classification: The Gruesome
Stock price: 155.83333333333334
Shares outstanding: 635868896
Book value: 28772187500
P/B ratio: 3.443935906043525
Market cap (USD): 99089569626.66667
Debt to equity: 0.4486972010730849
Current ratio: 0.880146771965711
Quick ratio: 0.6492761569363461
Buyback yield (%): 0
Retained earnings: 22750312500
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AIL.DE — annual report dated 2024-12-31
Total revenue: 28185208333.333336
Gross profit: 17760000000
Operating income: 5372291666.666667
Net income: 3583333333.3333335
Capital expenditures: 3588541666.666667
Operating cash flow: 6585625000
Depreciation & amortization: 2609479166.666667
Net tangible assets: 10615729166.666668
Owner earnings: 2604270833.333333
Return on net tangible assets (%): 24.53218985192962
Capex to operating income (%): 66.79722340714314
Buffett classification: The Good
Stock price: 155.83333333333334
P/E ratio: 27.65290315162791
Shares outstanding: 635868896
Book value: 28772187500
P/B ratio: 3.443935906043525
Market cap (USD): 99089569626.66667
Debt to equity: 0.4486972010730849
Current ratio: 0.880146771965711
Quick ratio: 0.6492761569363461
Effective tax rate (%): 23.999381516168935
Interest coverage ratio: 65.36628643852978
COGS to revenue (%): 36.98822520677956
Free cash flow (dilution-adjusted): 2913645833.3333335
Buyback yield (%): 0.24262560385767035
Retained earnings: 22750312500
Inventory turnover: 4.570789185239313
Receivables turnover: 9.02919878533053
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.16844330563381
FCF margin (%): 10.337499722815602
Revenue growth (%): -8.117013068865084
Rule of 40 score: 2.220486653950518
Financial ratios for AIL.DE — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 10760705882.352942
Buffett classification: The Gruesome
Stock price: 202.16470588235296
Shares outstanding: 635868896
Book value: 29672117647.058826
P/B ratio: 4.332358406927478
Market cap (USD): 128550248339.57648
Debt to equity: 0.5016751713829184
Current ratio: 0.8431434234120867
Quick ratio: 0.614328708801292
Buyback yield (%): 0
Retained earnings: 22917647058.82353
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AIL.DE — quarterly report dated 2025-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 203.87058823529412
Shares outstanding: 635868896
Market cap (USD): 129634965868.04706
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALOKW.PA — annual report dated 2022-12-31
Total revenue: 44441489.36170213
Gross profit: 22646808.5106383
Operating income: 3505319.1489361706
Net income: 2342553.1914893617
Capital expenditures: 3343617.021276596
Operating cash flow: -676595.7446808511
Depreciation & amortization: 1105319.1489361704
Net tangible assets: 20610638.297872342
Owner earnings: 104255.31914893631
Return on net tangible assets (%): 0.505832559099825
Capex to operating income (%): 95.38694992412746
Buffett classification: The Gruesome
Stock price: 14.340425531914894
P/E ratio: 50.776221580381474
Shares outstanding: 8294454
Book value: 30946808.510638297
P/B ratio: 3.8435627335854248
Market cap (USD): 118945999.91489363
Debt to equity: 0.6244413887933998
Current ratio: 2.5781852276278783
Quick ratio: 2.300916762162726
Effective tax rate (%): 12.779552715654951
Interest coverage ratio: 4.962349397590361
COGS to revenue (%): 49.04129263913825
R&D to revenue (%): 0.3183722321962897
SG&A to revenue (%): 1.910233393177738
Free cash flow (dilution-adjusted): -4068085.106382979
Buyback yield (%): 0
Inventory turnover: 3.8487694908885968
Receivables turnover: 3.6946139559564872
Capitalized R&D asset: 187932.5435203095
ROCI (R&D-adjusted, %): 7.674161298967157
Rosenberg metric: 82.74084408789678
FCF margin (%): -9.15380011968881
Revenue growth (%): 55.26643893241969
Rule of 40 score: 46.11263881273088
Financial ratios for ALOKW.PA — annual report dated 2023-12-31
Total revenue: 91630000
Gross profit: 47624444.44444444
Operating income: 11743333.333333334
Net income: 8397777.777777778
Capital expenditures: 5282222.222222222
Operating cash flow: -8160000
Depreciation & amortization: 2747777.7777777775
Net tangible assets: 28878888.888888888
Owner earnings: 5863333.333333334
Return on net tangible assets (%): 20.303181870647535
Capex to operating income (%): 44.98060365219037
Buffett classification: The Good
Stock price: 21.77777777777778
P/E ratio: 21.50983043133104
Shares outstanding: 8294454
Book value: 40385555.55555555
P/B ratio: 4.472756992323989
Market cap (USD): 180634776
Debt to equity: 0.6451976779376565
Current ratio: 2.7944675303511777
Quick ratio: 2.4537195469730304
Effective tax rate (%): 23.985872855701313
Interest coverage ratio: 12.010227272727274
COGS to revenue (%): 48.02527071434634
R&D to revenue (%): 0.2073556695405435
SG&A to revenue (%): 1.7182630628008781
Free cash flow (dilution-adjusted): -13584444.444444444
Buyback yield (%): 0
Inventory turnover: 4.7351745576279285
Receivables turnover: 3.7082152974504248
Capitalized R&D asset: 307672.87234042556
ROCI (R&D-adjusted, %): 17.361933933649453
Rosenberg metric: 176.5336675020885
FCF margin (%): -14.825324069021548
Revenue growth (%): 106.18120885697186
Rule of 40 score: 91.35588478795032
Financial ratios for ALOKW.PA — annual report dated 2024-12-31
Total revenue: 59455208.333333336
Gross profit: 32094791.666666668
Operating income: -1808333.3333333335
Net income: -3764583.3333333335
Capital expenditures: 4002083.3333333335
Operating cash flow: 9294791.666666668
Depreciation & amortization: 3704166.666666667
Net tangible assets: 22136458.333333336
Owner earnings: -4062500
Return on net tangible assets (%): -18.352077549291796
Buffett classification: The Gruesome
Stock price: 5.062500000000001
Shares outstanding: 8294454
Book value: 34071875
P/B ratio: 1.232414517105384
Market cap (USD): 41990673.37500001
Debt to equity: 0.6679201443027913
Current ratio: 2.1261939218523875
Quick ratio: 1.695141616704569
Interest coverage ratio: -1.6377358490566039
COGS to revenue (%): 46.01853636315854
R&D to revenue (%): 0.23301855388335058
SG&A to revenue (%): 2.0691346777160677
Free cash flow (dilution-adjusted): 5025000
Buyback yield (%): 0
Inventory turnover: 2.5195203836930458
Receivables turnover: 5.426086129860252
Capitalized R&D asset: 312533.1560283688
ROCI (R&D-adjusted, %): -3.822977678474552
Rosenberg metric: -81.73501461988302
FCF margin (%): 8.451740631077316
Revenue growth (%): -35.113818254574554
Rule of 40 score: -26.66207762349724
Financial ratios for ALOKW.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 22136458.333333336
Buffett classification: The Gruesome
Stock price: 5.062500000000001
Shares outstanding: 8294454
Book value: 34071875
P/B ratio: 1.232414517105384
Market cap (USD): 41990673.37500001
Debt to equity: 0.6679201443027913
Current ratio: 2.1261939218523875
Quick ratio: 1.695141616704569
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALOKW.PA — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 16712941.176470589
Buffett classification: The Gruesome
Stock price: 2.7529411764705882
Shares outstanding: 8294454
Book value: 30571764.705882356
P/B ratio: 0.7469030385592241
Market cap (USD): 22834143.952941176
Debt to equity: 1.120141614715616
Current ratio: 1.7590289353335897
Quick ratio: 1.2898662221652348
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMSC — annual report dated 2022-03-31
Total revenue: 108435000
Gross profit: 13492000
Operating income: -26939000
Net income: -19193000
Capital expenditures: 938000
Operating cash flow: -18977000
Depreciation & amortization: 5341000
Net tangible assets: 54607000
Owner earnings: -14790000
Return on net tangible assets (%): -27.084439723844927
Buffett classification: The Gruesome
Stock price: 7.61
Shares outstanding: 48462307
Book value: 109389000
P/B ratio: 3.3714373133496056
Market cap (USD): 368798156.27000004
Debt to equity: 0.03475669400031082
Current ratio: 1.748128381884219
Quick ratio: 1.3095767548736195
COGS to revenue (%): 87.55752294001014
R&D to revenue (%): 9.655554018536451
SG&A to revenue (%): 25.35528196615484
Free cash flow (dilution-adjusted): -24576000
Buyback yield (%): 0.012472947388143403
Retained earnings: -1020506000
Inventory turnover: 4.0117890644806895
Receivables turnover: 5.34689349112426
Capitalized R&D asset: 10470000
ROCI (R&D-adjusted, %): -15.30680327931714
FCF margin (%): -22.664268916862635
Rule of 40 score: -22.664268916862635
Financial ratios for AMSC — annual report dated 2023-03-31
Total revenue: 105984000
Gross profit: 8521000
Operating income: -31891000
Net income: -35041000
Capital expenditures: 1236000
Operating cash flow: -22485000
Depreciation & amortization: 5361000
Net tangible assets: 29799000
Owner earnings: -30916000
Return on net tangible assets (%): -103.74844793449445
Buffett classification: The Gruesome
Stock price: 4.91
Shares outstanding: 48462307
Book value: 81797000
P/B ratio: 2.909030005623678
Market cap (USD): 237949927.37
Debt to equity: 0.03767864347103195
Current ratio: 1.2623412755029249
Quick ratio: 0.8225971370143149
COGS to revenue (%): 91.96010718599034
R&D to revenue (%): 8.459767512077294
SG&A to revenue (%): 27.079559178743963
Free cash flow (dilution-adjusted): -28450000
Buyback yield (%): 0
Retained earnings: -1055547000
Inventory turnover: 2.6351322121883958
Receivables turnover: 3.456187836295451
Capitalized R&D asset: 15980900
ROCI (R&D-adjusted, %): -27.369076861834735
Rosenberg metric: -0.4747851002865329
FCF margin (%): -26.843674516908212
Revenue growth (%): -2.2603402960298795
Rule of 40 score: -29.104014812938093
Financial ratios for AMSC — annual report dated 2024-03-31
Total revenue: 145639000
Gross profit: 35283000
Operating income: -6460000
Net income: -11111000
Capital expenditures: 934000
Operating cash flow: 2138000
Depreciation & amortization: 4815000
Net tangible assets: 94731000
Owner earnings: -7230000
Return on net tangible assets (%): -7.632137315134433
Buffett classification: The Gruesome
Stock price: 13.51
Shares outstanding: 48462307
Book value: 144571000
P/B ratio: 4.528748971577979
Market cap (USD): 654725767.5699999
Debt to equity: 0.018738197840507433
Current ratio: 2.112310932900213
Quick ratio: 1.581184651304436
COGS to revenue (%): 75.77365952801104
R&D to revenue (%): 5.486854482659178
SG&A to revenue (%): 21.697484876990366
Free cash flow (dilution-adjusted): -3448000
Buyback yield (%): 0
Retained earnings: -1066658000
Inventory turnover: 2.6365004658718973
Receivables turnover: 5.532345679012345
Capitalized R&D asset: 17453320
ROCI (R&D-adjusted, %): -4.440261775152642
Rosenberg metric: 2.9848315859915235
FCF margin (%): -2.367497716957683
Revenue growth (%): 37.416025060386474
Rule of 40 score: 35.04852734342879
Financial ratios for AMSC — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 23.6
Shares outstanding: 48462307
Market cap (USD): 1143710445.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMSC — quarterly report dated 2024-12-31
Total revenue: 61403000
Gross profit: 16326000
Operating income: 1315000
Net income: 2465000
Capital expenditures: 524000
Operating cash flow: 5874000
Depreciation & amortization: 1796000
Net tangible assets: 137104000
Owner earnings: 3737000
Return on net tangible assets (%): 2.7256681059633565
Capex to operating income (%): 39.847908745247146
Buffett classification: The Good
Stock price: 24.63
P/E ratio: 121.05746667444218
Shares outstanding: 48462307
Book value: 192676000
P/B ratio: 6.194993779245988
Market cap (USD): 1193626621.4099998
Debt to equity: 0.017646203990118126
Current ratio: 1.9672875269332057
Quick ratio: 1.2530141249700741
Effective tax rate (%): -3.1812473838426123
COGS to revenue (%): 73.4117225542726
R&D to revenue (%): 4.885754767682361
SG&A to revenue (%): 18.83784179926062
Free cash flow (dilution-adjusted): 2489000
Buyback yield (%): 0
Retained earnings: -1061830000
Inventory turnover: 0.6043465436799486
Receivables turnover: 1.3912541067180242
Capitalized R&D asset: 3000000
ROCI (R&D-adjusted, %): 1.58724078658195
FCF margin (%): 4.053547872253799
Rule of 40 score: 4.053547872253799
Financial ratios for AMSC — annual report dated 2025-03-31
Total revenue: 222818000
Gross profit: 61854000
Operating income: 5605000
Net income: 6033000
Capital expenditures: 2415000
Operating cash flow: 28285000
Depreciation & amortization: 6536000
Net tangible assets: 143035000
Owner earnings: 10154000
Return on net tangible assets (%): 7.098961792568252
Capex to operating income (%): 43.08652988403212
Buffett classification: The Good
Stock price: 18.14
P/E ratio: 145.71626868556274
Shares outstanding: 48462307
Book value: 197114000
P/B ratio: 4.459887420376026
Market cap (USD): 879106248.98
Debt to equity: 0.017091632253416804
Current ratio: 2.070055330580169
Quick ratio: 1.3566817689747805
Effective tax rate (%): -154.98732037193577
COGS to revenue (%): 72.24012422694756
R&D to revenue (%): 5.12750316401727
SG&A to revenue (%): 19.33910186789218
Free cash flow (dilution-adjusted): 18076000
Buyback yield (%): 0.014332738522356532
Retained earnings: -1060625000
Inventory turnover: 2.261715072573733
Receivables turnover: 4.824362360888581
Capitalized R&D asset: 19737750
ROCI (R&D-adjusted, %): 3.2839504298181774
Rosenberg metric: 3.3251157552246275
FCF margin (%): 8.112450520155463
Revenue growth (%): 52.993360294975936
Rule of 40 score: 61.1058108151314
Financial ratios for AMSC — quarterly report dated 2025-03-31
Total revenue: 66655000
Gross profit: 17691000
Operating income: 1653000
Net income: 1205000
Capital expenditures: 1039000
Operating cash flow: 6290000
Depreciation & amortization: 1799000
Net tangible assets: 143035000
Owner earnings: 1965000
Return on net tangible assets (%): 1.3737896319082743
Capex to operating income (%): 62.85541439806413
Buffett classification: The Good
Stock price: 18.14
P/E ratio: 182.38718858506223
Shares outstanding: 48462307
Book value: 197114000
P/B ratio: 4.459887420376026
Market cap (USD): 879106248.98
Debt to equity: 0.017091632253416804
Current ratio: 2.070055330580169
Quick ratio: 1.3566817689747805
Effective tax rate (%): 49.97924449979244
COGS to revenue (%): 73.45885529967744
R&D to revenue (%): 5.240417072987773
SG&A to revenue (%): 18.154677068486986
Free cash flow (dilution-adjusted): 2390000
Buyback yield (%): 0
Retained earnings: -1060625000
Inventory turnover: 0.6879961781112564
Receivables turnover: 1.4431862469146495
Capitalized R&D asset: 5503000
ROCI (R&D-adjusted, %): 1.3787416381516076
Rosenberg metric: 0.455
FCF margin (%): 3.5856274848098417
Revenue growth (%): 8.553328013289253
Rule of 40 score: 12.138955498099094
Financial ratios for AMSC — quarterly report dated 2025-06-30
Total revenue: 72358000
Gross profit: 24489000
Operating income: 5644000
Net income: 6724000
Capital expenditures: 814000
Operating cash flow: 4125000
Depreciation & amortization: 1472000
Net tangible assets: 279373000
Owner earnings: 7382000
Return on net tangible assets (%): 2.64234553804412
Capex to operating income (%): 14.422395464209782
Buffett classification: The Great
Stock price: 36.69
P/E ratio: 171.06812043775253
Shares outstanding: 48462307
Book value: 333116000
P/B ratio: 5.337726329056545
Market cap (USD): 1778082043.83
Debt to equity: 0.011287359358301613
Current ratio: 3.3126673630234547
Quick ratio: 2.632750925838002
Effective tax rate (%): 2.874476383070923
COGS to revenue (%): 66.15578097791537
R&D to revenue (%): 5.948201995632826
SG&A to revenue (%): 19.630172199342162
Free cash flow (dilution-adjusted): -1215000
Buyback yield (%): 0
Retained earnings: -1053901000
Inventory turnover: 0.668542778134689
Receivables turnover: 1.3232023992392656
Capitalized R&D asset: 7634310
ROCI (R&D-adjusted, %): 1.7875931127238647
Rosenberg metric: 1.9461780704265674
FCF margin (%): -1.6791508886370548
Revenue growth (%): 8.555997299527416
Rule of 40 score: 6.876846410890361
Financial ratios for AMSC — quarterly report dated 2025-09-30
Total revenue: 65862000
Gross profit: 20439000
Operating income: 2965000
Net income: 4750000
Capital expenditures: 1392000
Operating cash flow: 6487000
Depreciation & amortization: 1654000
Net tangible assets: 288776000
Owner earnings: 5012000
Return on net tangible assets (%): 1.735601296506635
Capex to operating income (%): 46.94772344013491
Buffett classification: The Good
Stock price: 59.39
P/E ratio: 190.05390997952986
Shares outstanding: 48462307
Book value: 342182000
P/B ratio: 8.411244345786745
Market cap (USD): 2878176412.73
Debt to equity: 0.01066391569398741
Current ratio: 3.9048334927793724
Quick ratio: 3.0454535100906566
Effective tax rate (%): 2.4039449352784055
COGS to revenue (%): 68.96693085542498
R&D to revenue (%): 5.66183838935957
SG&A to revenue (%): 20.35771765206037
Free cash flow (dilution-adjusted): 1329000
Buyback yield (%): 0
Retained earnings: -1049151000
Inventory turnover: 0.6019719840438925
Receivables turnover: 1.6519187358916478
Capitalized R&D asset: 7765370
ROCI (R&D-adjusted, %): 0.7801635591564899
Rosenberg metric: -0.9409851301115242
FCF margin (%): 2.017855516079074
Revenue growth (%): -8.977583681140993
Rule of 40 score: -6.95972816506192
Financial ratios for AMSC — quarterly report dated 2025-12-31
Total revenue: 74529000
Gross profit: 22852000
Operating income: 3359000
Net income: 117806000
Capital expenditures: 893000
Operating cash flow: 3249000
Depreciation & amortization: 1883000
Net tangible assets: 356611000
Owner earnings: 118796000
Return on net tangible assets (%): 33.31248895855708
Capex to operating income (%): 26.58529324203632
Buffett classification: The Good
Stock price: 28.78
P/E ratio: 10.68893125999157
Shares outstanding: 48462307
Book value: 536836000
P/B ratio: 2.59808432269818
Market cap (USD): 1394745195.46
Debt to equity: 0.02120386859301537
Current ratio: 2.664750737946868
Quick ratio: 1.800467366349623
Effective tax rate (%): -2068.3416160500647
COGS to revenue (%): 69.33810999745066
R&D to revenue (%): 4.7538542044036545
SG&A to revenue (%): 20.716767969515224
Free cash flow (dilution-adjusted): -1466000
Buyback yield (%): 0
Retained earnings: -931345000
Inventory turnover: 0.4902569064966606
Receivables turnover: 1.190920566945239
Capitalized R&D asset: 7461750
ROCI (R&D-adjusted, %): 0.5030005802687417
Rosenberg metric: 0.6470903727540895
FCF margin (%): -1.9670195494371319
Revenue growth (%): 13.15933315113419
Rule of 40 score: 11.192313601697059
Financial ratios for AMWL — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 120.8
Shares outstanding: 15061188
Market cap (USD): 1819391510.3999999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMWL — annual report dated 2022-12-31
Total revenue: 277190000
Gross profit: 116768000
Operating income: -275853000
Net income: -270429000
Capital expenditures: 292000
Operating cash flow: -192323000
Depreciation & amortization: 26167000
Net tangible assets: 493618000
Owner earnings: -244554000
Return on net tangible assets (%): -49.543169009233864
Buffett classification: The Gruesome
Stock price: 56.6
Shares outstanding: 15061188
Book value: 1083851000
P/B ratio: 0.786513312992284
Market cap (USD): 852463240.8000001
Debt to equity: 0.013695609451852699
Current ratio: 5.493932804937925
Quick ratio: 5.41733008346777
COGS to revenue (%): 57.8743821927198
R&D to revenue (%): 49.96103755546737
SG&A to revenue (%): 82.24719506475702
Free cash flow (dilution-adjusted): -270445000
Buyback yield (%): 0.04223055995495542
Retained earnings: -1082028000
Inventory turnover: 18.361222387547212
Receivables turnover: 4.748680874391832
Capitalized R&D asset: 138487000
ROCI (R&D-adjusted, %): -14.776981205400805
FCF margin (%): -97.56665103358706
Rule of 40 score: -97.56665103358706
Financial ratios for AMWL — annual report dated 2023-12-31
Total revenue: 259047000
Gross profit: 94760000
Operating income: -255664000
Net income: -675164000
Capital expenditures: 192000
Operating cash flow: -148343000
Depreciation & amortization: 31512000
Net tangible assets: 343971000
Owner earnings: -643844000
Return on net tangible assets (%): -187.17973317518047
Buffett classification: The Gruesome
Stock price: 29.8
Shares outstanding: 15061188
Book value: 480186000
P/B ratio: 0.9346865639564669
Market cap (USD): 448823402.40000004
Debt to equity: 0.02454465561261678
Current ratio: 4.7931383732955215
Quick ratio: 4.722219260743947
COGS to revenue (%): 63.41976552517497
R&D to revenue (%): 40.85243218412103
SG&A to revenue (%): 82.26499438325864
Free cash flow (dilution-adjusted): -235837000
Buyback yield (%): 0.13056360182345073
Retained earnings: -1757778000
Inventory turnover: 24.697384245339748
Receivables turnover: 4.784231522180771
Capitalized R&D asset: 198613290
ROCI (R&D-adjusted, %): -33.299915111313574
Rosenberg metric: -0.15891744351455372
FCF margin (%): -91.0402359417403
Revenue growth (%): -6.545329918106714
Rule of 40 score: -97.58556585984702
Financial ratios for AMWL — quarterly report dated 2024-09-30
Capital expenditures: 4733000
Buffett classification: The Gruesome
Stock price: 9.48
Shares outstanding: 15061188
Market cap (USD): 142780062.24
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMWL — quarterly report dated 2024-12-31
Capital expenditures: 2416000
Buffett classification: The Gruesome
Stock price: 7.25
Shares outstanding: 15061188
Market cap (USD): 109193613
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMWL — annual report dated 2024-12-31
Total revenue: 254364000
Gross profit: 98952000
Operating income: -217534000
Net income: -208143000
Capital expenditures: 119000
Operating cash flow: -127338000
Depreciation & amortization: 32975000
Net tangible assets: 203234000
Owner earnings: -175287000
Return on net tangible assets (%): -86.2488559985042
Buffett classification: The Gruesome
Stock price: 7.25
Shares outstanding: 15061188
Book value: 316244000
P/B ratio: 0.345282797460189
Market cap (USD): 109193613
Debt to equity: 0.025932507810424863
Current ratio: 2.849042359095117
Quick ratio: 2.8233554730683155
COGS to revenue (%): 61.09905489770565
R&D to revenue (%): 33.83536978503247
SG&A to revenue (%): 77.62340582786872
Free cash flow (dilution-adjusted): -190102000
Buyback yield (%): 0.0027474134407476742
Retained earnings: -1965924000
Inventory turnover: 54.37858642407278
Receivables turnover: 3.538485080336649
Capitalized R&D asset: 202669800
ROCI (R&D-adjusted, %): -45.81093623232155
Rosenberg metric: 0.03961181928997326
FCF margin (%): -74.7362048088566
Revenue growth (%): -1.8077800553567498
Rule of 40 score: -76.54398486421334
Financial ratios for AMWL — quarterly report dated 2025-03-31
Total revenue: 66833000
Gross profit: 35259000
Operating income: -30411000
Net income: -18356000
Capital expenditures: 9000
Operating cash flow: -25108000
Depreciation & amortization: 7801000
Net tangible assets: 203165000
Owner earnings: -10564000
Return on net tangible assets (%): -5.199714517756504
Buffett classification: The Gruesome
Stock price: 7.88
Shares outstanding: 15061188
Book value: 305774000
P/B ratio: 0.38813686395834834
Market cap (USD): 118682161.44
Debt to equity: 0.02386075990764421
Current ratio: 2.9186616320143917
Quick ratio: 2.8949562903482717
COGS to revenue (%): 47.243128394655336
R&D to revenue (%): 33.07048912962159
SG&A to revenue (%): 53.51847141382251
Free cash flow (dilution-adjusted): -32456000
Buyback yield (%): 0.0008425866093663553
Retained earnings: -1984629000
Inventory turnover: 12.479841897233202
Receivables turnover: 0.9281845453030387
Capitalized R&D asset: 22102000
ROCI (R&D-adjusted, %): -4.68169659611619
FCF margin (%): -48.56283572486646
Rule of 40 score: -48.56283572486646
Financial ratios for AMWL — quarterly report dated 2025-06-30
Total revenue: 70898000
Gross profit: 39755000
Operating income: -20379000
Net income: -19531000
Capital expenditures: 0
Operating cash flow: -4724000
Depreciation & amortization: 8224000
Net tangible assets: 198563000
Owner earnings: -11307000
Return on net tangible assets (%): -5.6944143672285366
Buffett classification: The Gruesome
Stock price: 8.89
Shares outstanding: 15061188
Book value: 294573000
P/B ratio: 0.4545357562302044
Market cap (USD): 133893961.32000001
Debt to equity: 0.021689021057598627
Current ratio: 3.2946562627963054
Quick ratio: 3.2698143682606124
COGS to revenue (%): 43.92648593754408
R&D to revenue (%): 25.72286947445626
SG&A to revenue (%): 47.49499280656718
Free cash flow (dilution-adjusted): -10734000
Buyback yield (%): 0.0007468596717443059
Retained earnings: -2004326000
Inventory turnover: 14.259615384615385
Receivables turnover: 1.3237858729951266
Capitalized R&D asset: 33045340
ROCI (R&D-adjusted, %): -4.670167159927795
Rosenberg metric: 0.2034205049316804
FCF margin (%): -15.1400603684166
Revenue growth (%): 6.082324600122694
Rule of 40 score: -9.057735768293906
Financial ratios for AMWL — quarterly report dated 2025-09-30
Total revenue: 56286000
Gross profit: 29507000
Operating income: -29332000
Net income: -31911000
Capital expenditures: 0
Operating cash flow: -18766000
Depreciation & amortization: 9443000
Net tangible assets: 180355000
Owner earnings: -22468000
Return on net tangible assets (%): -12.457652962213412
Buffett classification: The Gruesome
Stock price: 6.15
Shares outstanding: 15061188
Book value: 267363000
P/B ratio: 0.34644399636449325
Market cap (USD): 92626306.2
Debt to equity: 0.020421673904018132
Current ratio: 3.1353613837917838
Quick ratio: 3.1142830714442633
COGS to revenue (%): 47.578438688128486
R&D to revenue (%): 33.013538002345165
SG&A to revenue (%): 54.74540738371887
Free cash flow (dilution-adjusted): -22849000
Buyback yield (%): 0.0010796069076108748
Retained earnings: -2036705000
Inventory turnover: 14.690071311025783
Receivables turnover: 1.0127388535031847
Capitalized R&D asset: 38094450
ROCI (R&D-adjusted, %): -9.77079186860835
Rosenberg metric: -0.5619345287053792
FCF margin (%): -40.59446398749245
Revenue growth (%): -20.609890264887586
Rule of 40 score: -61.20435425238004
Financial ratios for AMWL — annual report dated 2025-12-31
Total revenue: 249325000
Gross profit: 132858000
Operating income: -105274000
Net income: -94967000
Capital expenditures: 21000
Operating cash flow: -65953000
Depreciation & amortization: 33961000
Net tangible assets: 169510000
Owner earnings: -61027000
Return on net tangible assets (%): -36.00200578136983
Buffett classification: The Gruesome
Stock price: 4.91
Shares outstanding: 15061188
Book value: 247788000
P/B ratio: 0.2984423502348782
Market cap (USD): 73950433.08
Debt to equity: 0.018257542738147125
Current ratio: 3.3693146119594615
Quick ratio: 3.3531018657633784
COGS to revenue (%): 46.7133259801464
R&D to revenue (%): 29.223302917878268
SG&A to revenue (%): 52.66619873658879
Free cash flow (dilution-adjusted): -87984000
Buyback yield (%): 0.0054090284984170105
Retained earnings: -2061628000
Inventory turnover: 98.11962931760742
Receivables turnover: 5.017306260439096
Capitalized R&D asset: 165447460
ROCI (R&D-adjusted, %): -29.00434271910569
Rosenberg metric: 0.39395805495846165
FCF margin (%): -35.288879975935025
Revenue growth (%): -1.9810193266342722
Rule of 40 score: -37.2698993025693
Financial ratios for AMWL — quarterly report dated 2025-12-31
Total revenue: 55308000
Gross profit: 28337000
Operating income: -25152000
Net income: -24922000
Capital expenditures: 12000
Operating cash flow: -17355000
Depreciation & amortization: 8494000
Net tangible assets: 169510000
Owner earnings: -16440000
Return on net tangible assets (%): -9.698542858828388
Buffett classification: The Gruesome
Stock price: 4.91
Shares outstanding: 15061188
Book value: 247788000
P/B ratio: 0.2984423502348782
Market cap (USD): 73950433.08
Debt to equity: 0.018257542738147125
Current ratio: 3.3693146119594615
Quick ratio: 3.3531018657633784
COGS to revenue (%): 48.766905330151154
R&D to revenue (%): 25.20431040717437
SG&A to revenue (%): 56.149200838938306
Free cash flow (dilution-adjusted): -21945000
Buyback yield (%): 0.0013522571246042526
Retained earnings: -2061628000
Inventory turnover: 22.722830665543388
Receivables turnover: 1.1129937818203772
Capitalized R&D asset: 32408150
ROCI (R&D-adjusted, %): -9.941180416669686
Rosenberg metric: -0.0629641588634162
FCF margin (%): -39.67780429594272
Revenue growth (%): -1.7375546317023771
Rule of 40 score: -41.4153589276451
Financial ratios for AUR.AX — annual report dated 2021-06-30
Operating income: -1772760.1503759397
Net income: -1738800.751879699
Capital expenditures: 25993.984962406015
Depreciation & amortization: 11643.609022556391
Net tangible assets: 18089991.72932331
Owner earnings: -1753151.1278195488
Return on net tangible assets (%): -9.691276558063572
Buffett classification: The Gruesome
Stock price: 0.03759398496240601
Shares outstanding: 1286625957
Book value: 18089991.729323305
P/B ratio: 2.6738208399119374
Market cap (USD): 48369396.879699245
Debt to equity: 0
Current ratio: 12.807088204362206
Quick ratio: 12.807088204362206
Interest coverage ratio: -387.3453261048135
Free cash flow (dilution-adjusted): -1929320.3007518796
Buyback yield (%): 0.5051025097576203
Retained earnings: -80413686.46616541
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.776260693098058
Rule of 40 score: 0
Financial ratios for AUR.AX — annual report dated 2022-06-30
Operating income: -1127034.4827586208
Net income: -1097303.448275862
Capital expenditures: 68466.89655172414
Depreciation & amortization: 18790.344827586207
Net tangible assets: 17003220
Owner earnings: -1146979.9999999998
Return on net tangible assets (%): -6.7456634684489165
Buffett classification: The Gruesome
Stock price: 0.013793103448275864
Shares outstanding: 1286625957
Book value: 17003220.000000004
P/B ratio: 1.0437178913251683
Market cap (USD): 17746564.92413793
Debt to equity: 0
Current ratio: 28.53296025277256
Quick ratio: 28.53296025277256
Interest coverage ratio: -3071.8045112781956
Free cash flow (dilution-adjusted): -1344575.8620689656
Buyback yield (%): 0.7658014317520878
Retained earnings: -74634950.34482759
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.620475125839464
Rule of 40 score: 0
Financial ratios for AUR.AX — annual report dated 2023-06-30
Operating income: -3389338.4105960266
Net income: -3242047.0198675497
Capital expenditures: 46357.615894039736
Depreciation & amortization: 25288.741721854305
Net tangible assets: 13085548.34437086
Owner earnings: -3263115.894039735
Return on net tangible assets (%): -24.936791398913456
Buffett classification: The Gruesome
Stock price: 0.006622516556291391
Shares outstanding: 1286625957
Book value: 13085548.34437086
P/B ratio: 0.6511535839193311
Market cap (USD): 8520701.701986754
Debt to equity: 0.0023432654941415074
Current ratio: 9.450935130642451
Quick ratio: 9.450935130642451
Interest coverage ratio: -14060.167582417584
Free cash flow (dilution-adjusted): -717762.9139072847
Buyback yield (%): 0
Retained earnings: -74911370.1986755
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -25.826268608784464
Rule of 40 score: 0
Financial ratios for AUR.AX — annual report dated 2024-06-30
Operating income: -3130225.3333333335
Net income: -2950642
Capital expenditures: 83333.33333333333
Depreciation & amortization: 34424
Net tangible assets: 10222143.333333334
Owner earnings: -2999551.3333333335
Return on net tangible assets (%): -29.3436634130546
Buffett classification: The Gruesome
Stock price: 0.006666666666666667
Shares outstanding: 1286625957
Book value: 10222143.333333334
P/B ratio: 0.8391103607430014
Market cap (USD): 8577506.38
Debt to equity: 0.0013226841207144098
Current ratio: 8.774517584848242
Quick ratio: 8.774517584848242
Interest coverage ratio: -1404.9485338120887
Free cash flow (dilution-adjusted): -579876
Buyback yield (%): 0
Retained earnings: -76904041.33333333
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -30.59670354840823
Rule of 40 score: 0
Financial ratios for AXIL — annual report dated 2024-05-31
Total revenue: 27498539
Gross profit: 20176701
Operating income: 1503380
Net income: 3332722
Capital expenditures: 138445
Operating cash flow: 2677
Depreciation & amortization: 130610
Net tangible assets: 5234467
Owner earnings: 3324887
Return on net tangible assets (%): 63.51911283421979
Capex to operating income (%): 9.208915909483963
Buffett classification: The Great
Stock price: 8.68
P/E ratio: 17.756591626904374
Shares outstanding: 6817717
Book value: 7695786
P/B ratio: 7.689634763752526
Market cap (USD): 59177783.559999995
Debt to equity: 0.02382420717000187
Current ratio: 2.847295165017003
Quick ratio: 1.6342971610535213
Effective tax rate (%): -12.350744196768352
Interest coverage ratio: 342.29963570127507
COGS to revenue (%): 26.62628003618665
SG&A to revenue (%): 67.90659314663954
Free cash flow (dilution-adjusted): -425031
Buyback yield (%): 2.1063478978326238
Retained earnings: -134270
Inventory turnover: 2.157274125720421
Receivables turnover: 53.93615385369777
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 18.387009504035802
FCF margin (%): -1.5456493888638956
Revenue growth (%): 16.91045208187551
Rule of 40 score: 15.364802693011613
Financial ratios for AXIL — quarterly report dated 2024-08-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.31
Shares outstanding: 6817717
Market cap (USD): 36202077.269999996
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AXIL — quarterly report dated 2024-11-30
Capital expenditures: 0
Depreciation & amortization: 11405
Buffett classification: The Gruesome
Stock price: 4.24
Shares outstanding: 6817717
Market cap (USD): 28907120.080000002
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AXIL — quarterly report dated 2025-02-28
Total revenue: 6922367
Gross profit: 4966428
Operating income: 583109
Net income: 576662
Capital expenditures: 88305
Operating cash flow: -169944
Depreciation & amortization: 45666
Net tangible assets: 7146858
Owner earnings: 534023
Return on net tangible assets (%): 7.4721367067877935
Capex to operating income (%): 15.143823881984328
Buffett classification: The Great
Stock price: 8.16
P/E ratio: 24.118361674603147
Shares outstanding: 6817717
Book value: 9656866
P/B ratio: 5.7609343155429515
Market cap (USD): 55632570.72
Debt to equity: 0.08814640277705003
Current ratio: 3.7763723741719057
Quick ratio: 2.6560805567586256
Effective tax rate (%): 8.429575686744041
Interest coverage ratio: 458.77970102281665
COGS to revenue (%): 28.255349651354805
SG&A to revenue (%): 63.321101004901934
Free cash flow (dilution-adjusted): -576152
Buyback yield (%): 0
Retained earnings: 966293
Inventory turnover: 0.7126925167866913
Receivables turnover: 8.637950311334057
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.552786558788161
FCF margin (%): -8.32304903799524
Rule of 40 score: -8.32304903799524
Financial ratios for AXIL — quarterly report dated 2025-05-31
Total revenue: 5751309
Gross profit: 4023445
Operating income: 46087
Net income: -245575
Capital expenditures: 59395
Operating cash flow: 194431
Depreciation & amortization: 55497
Net tangible assets: 7103902
Owner earnings: -249473
Return on net tangible assets (%): -3.511774233372026
Capex to operating income (%): 128.87582181526244
Buffett classification: The Gruesome
Stock price: 6.15
P/E ratio: 126.64030768347897
Shares outstanding: 6817717
Book value: 9659708
P/B ratio: 4.340603209745057
Market cap (USD): 41928959.550000004
Debt to equity: 0.07841241163811577
Current ratio: 3.7581443091345546
Quick ratio: 2.729383017219257
Effective tax rate (%): 379.3227780431766
Interest coverage ratio: 34.62584522915101
COGS to revenue (%): 30.042969348369216
SG&A to revenue (%): 69.15570003280992
Free cash flow (dilution-adjusted): -192506
Buyback yield (%): 0
Retained earnings: 720718
Inventory turnover: 0.6819641798537924
Receivables turnover: 5.727442746077097
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.442847395269959
FCF margin (%): -3.3471684446097405
Revenue growth (%): -16.917016968328895
Rule of 40 score: -20.264185412938634
Financial ratios for AXIL — annual report dated 2025-05-31
Total revenue: 26257522
Gross profit: 18641568
Operating income: 1161365
Net income: 854988
Capital expenditures: 213483
Operating cash flow: 1928661
Depreciation & amortization: 148498
Net tangible assets: 7103902
Owner earnings: 790003
Return on net tangible assets (%): 11.120691135660374
Capex to operating income (%): 18.38207626370693
Buffett classification: The Great
Stock price: 6.15
P/E ratio: 49.040407058344684
Shares outstanding: 6817717
Book value: 9659708
P/B ratio: 4.340603209745057
Market cap (USD): 41928959.550000004
Debt to equity: 0.07841241163811577
Current ratio: 3.7581443091345546
Quick ratio: 2.729383017219257
Effective tax rate (%): 34.67469835332086
Interest coverage ratio: 297.9386865059005
COGS to revenue (%): 29.004846687360676
SG&A to revenue (%): 66.57217310909994
Free cash flow (dilution-adjusted): 425429
Buyback yield (%): 0
Retained earnings: 720718
Inventory turnover: 3.005912400173978
Receivables turnover: 26.148560946535785
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.159491075741443
FCF margin (%): 1.620217627543071
Revenue growth (%): -4.51302885582394
Rule of 40 score: -2.892811228280869
Financial ratios for AXIL — quarterly report dated 2025-08-31
Total revenue: 6856218
Gross profit: 4634934
Operating income: 411738
Net income: 334294
Capital expenditures: 8367
Operating cash flow: -739194
Depreciation & amortization: 62087
Net tangible assets: 7588594
Owner earnings: 388014
Return on net tangible assets (%): 5.113121086725683
Capex to operating income (%): 2.0321175116214683
Buffett classification: The Great
Stock price: 5.62
P/E ratio: 57.58440583665599
Shares outstanding: 6817717
Book value: 10193214
P/B ratio: 3.7589291797464472
Market cap (USD): 38315569.54
Debt to equity: 0.0686341913355297
Current ratio: 2.5887736331424573
Quick ratio: 1.7274825940891319
Effective tax rate (%): 25.605316099627906
Interest coverage ratio: 320.9181605611847
COGS to revenue (%): 32.398094693021726
SG&A to revenue (%): 61.596582839110425
Free cash flow (dilution-adjusted): -1032903
Buyback yield (%): 0
Retained earnings: 1055012
Inventory turnover: 0.5711031499986373
Receivables turnover: 2.4673740108415614
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.79830806850567
FCF margin (%): -15.065200668940223
Revenue growth (%): 19.21143517067158
Rule of 40 score: 4.146234501731358
Financial ratios for AXIL — quarterly report dated 2025-11-30
Total revenue: 8134859
Gross profit: 5536237
Operating income: 903071
Net income: 704883
Capital expenditures: 28444
Operating cash flow: 934801
Depreciation & amortization: 67514
Net tangible assets: 8503892
Owner earnings: 743953
Return on net tangible assets (%): 8.748382505328149
Capex to operating income (%): 3.149696978421409
Buffett classification: The Great
Stock price: 5.1
P/E ratio: 25.374932640717407
Shares outstanding: 6817717
Book value: 11079119
P/B ratio: 3.138368375680413
Market cap (USD): 34770356.699999996
Debt to equity: 0.05800858353448501
Current ratio: 2.7527127581520316
Quick ratio: 1.7222118619788482
Effective tax rate (%): 24.85239840596675
Interest coverage ratio: 692.5391104294479
COGS to revenue (%): 31.944278321234577
SG&A to revenue (%): 56.954472105785726
Free cash flow (dilution-adjusted): 712935
Buyback yield (%): 0
Retained earnings: 1759895
Inventory turnover: 0.5506546729813632
Receivables turnover: 3.3341635756296495
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.744913415588196
FCF margin (%): 8.763950303256639
Revenue growth (%): 18.649363249534947
Rule of 40 score: 27.413313552791585
Financial ratios for BGDE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 795.6
Shares outstanding: 5521252
Market cap (USD): 4392708091.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BGDE — annual report dated 2022-12-31
Total revenue: 84385407
Gross profit: 36670512
Operating income: -55392323
Net income: -52762308
Capital expenditures: 59876269
Operating cash flow: 14256294
Depreciation & amortization: 64819805
Net tangible assets: 77072024
Owner earnings: -47818772
Return on net tangible assets (%): -62.04426654216321
Buffett classification: The Gruesome
Stock price: 27.6
Shares outstanding: 5521252
Book value: 76166120
P/B ratio: 2.0007131149650266
Market cap (USD): 152386555.20000002
Debt to equity: 0.4104507227097822
Current ratio: 0.572720815754996
Quick ratio: 0.572720815754996
Interest coverage ratio: -9.13477758681138
COGS to revenue (%): 56.54401240252358
SG&A to revenue (%): 34.20337476123093
Free cash flow (dilution-adjusted): -70788586
Buyback yield (%): 0
Retained earnings: -122257628
Receivables turnover: 7.91382928550053
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -56.62930117619105
FCF margin (%): -83.88723656923288
Rule of 40 score: -83.88723656923288
Financial ratios for BGDE — annual report dated 2023-12-31
Total revenue: 43571720
Gross profit: 15014716
Operating income: -53078120
Net income: -58545093
Capital expenditures: 4292734
Operating cash flow: -2545664
Depreciation & amortization: 39516692
Net tangible assets: 29238044
Owner earnings: -23321135
Return on net tangible assets (%): -79.7629793566218
Buffett classification: The Gruesome
Stock price: 64
Shares outstanding: 5521252
Book value: 30384630
P/B ratio: 11.62956823894186
Market cap (USD): 353360128
Debt to equity: 0.7197224715258997
Current ratio: 0.3777280429829868
Quick ratio: 0.3777280429829868
Interest coverage ratio: -17.409683249310376
COGS to revenue (%): 65.54022655061586
SG&A to revenue (%): 68.88029666949113
Free cash flow (dilution-adjusted): -18732526
Buyback yield (%): 0
Retained earnings: -182666465
Receivables turnover: 3.541025759803264
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -168.76443713572314
FCF margin (%): -42.99239506725922
Revenue growth (%): -48.365811638498116
Rule of 40 score: -91.35820670575734
Financial ratios for BGDE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 24.8
Shares outstanding: 5521252
Market cap (USD): 136927049.6
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BGDE — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 16.6
Shares outstanding: 5521252
Market cap (USD): 91652783.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BGDE — annual report dated 2024-12-31
Total revenue: 59265125
Gross profit: 20277214
Operating income: -29979343
Net income: -46131701
Capital expenditures: 838864
Operating cash flow: 3562603
Depreciation & amortization: 18836341
Net tangible assets: -3238837
Owner earnings: -28134224
Buffett classification: The Gruesome
Stock price: 16.6
Shares outstanding: 5521252
Book value: -3238837
Market cap (USD): 91652783.2
Debt to equity: -7.805632700873801
Current ratio: 0.419812735375024
Quick ratio: 0.419812735375024
Interest coverage ratio: -9.67812366834106
COGS to revenue (%): 65.78558806718117
SG&A to revenue (%): 54.63379517043118
Free cash flow (dilution-adjusted): -12460182
Buyback yield (%): 0
Retained earnings: -228798166
Receivables turnover: 3.8565528691515008
Capitalized R&D asset: 0
FCF margin (%): -21.02447603038043
Revenue growth (%): 36.017409916340235
Rule of 40 score: 14.992933885959804
Financial ratios for BGDE — quarterly report dated 2025-03-31
Total revenue: 13814373
Gross profit: 5923930
Operating income: -3482895
Net income: -310863
Capital expenditures: 0
Operating cash flow: -510385
Depreciation & amortization: 1846244
Net tangible assets: -1444026
Owner earnings: 1535381
Buffett classification: The Gruesome
Stock price: 10
Shares outstanding: 5521252
Book value: -1444026
Market cap (USD): 55212520
Debt to equity: -17.857321821075242
Current ratio: 0.3547380061083989
Quick ratio: 0.3547380061083989
Interest coverage ratio: -4.437572066533735
COGS to revenue (%): 57.11763393097898
SG&A to revenue (%): 57.03416289686112
Free cash flow (dilution-adjusted): -2617385
Buyback yield (%): 0
Retained earnings: -229109029
Receivables turnover: 1.2680770453042118
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -378.2881267384889
FCF margin (%): -18.946824441471215
Rule of 40 score: -18.946824441471215
Financial ratios for BGDE — quarterly report dated 2025-06-30
Total revenue: 9533183
Gross profit: 3933630
Operating income: -4436058
Net income: -8021433
Capital expenditures: 0
Operating cash flow: -2078599
Depreciation & amortization: 1775186
Net tangible assets: -8339902
Owner earnings: -6246247
Buffett classification: The Gruesome
Stock price: 7.6
Shares outstanding: 5521252
Book value: -8339902
Market cap (USD): 41961515.199999996
Debt to equity: -3.1898258516706792
Current ratio: 0.32049472677325386
Quick ratio: 0.32049472677325386
Interest coverage ratio: -5.36185781834708
COGS to revenue (%): 58.73749617520192
SG&A to revenue (%): 72.41620138835057
Free cash flow (dilution-adjusted): -3104996
Buyback yield (%): 0
Retained earnings: -237130462
Receivables turnover: 0.7996135457118034
Capitalized R&D asset: 0
FCF margin (%): -32.570401722069114
Revenue growth (%): -30.99083831021502
Rule of 40 score: -63.56124003228413